ArticleFrontiers in pharmacology2025

Ocular toxicity events of cyclin-dependent kinase 4/6 inhibitors in breast cancer: a pharmacovigilance study based on the faers database.

Mengdi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.